BioSpace News Archive

The Fertility Partners (“TFP”) announced today that it has partnered with leading genetic testing laboratory Sequence46 in Los Angeles, California . This investment significantly expands the comprehensive services offered by its Canada -wide network of fertility clinics in the pursuit of global best IVF clinical outcomes and

Tiziana Life Sciences plc (Nasdaq: TLSA / AIM: TILS) (" Tiziana " or the " Company "), is pleased to note the publication of a new analyst research note from H C Wainwright & Co which is available on the Company’s website at https://ir.tizianalifesciences.com/static-files/0bae55ef-6589-43f2-a4bd-65be16b3dce1 About Tiziana Life Sciences Tiziana Life Sciences plc is a dual listed (NASDAQ: TLSA & UK AIMS: TILS) biotechnology c

A new study released today in the National Kidney Foundation’s American Journal of Kidney Diseases (AJKD) shows that the drug canagliflozin reduces the risk of adverse cardiovascular and kidney outcomes in people with type 2 diabetes

Trinity Life Sciences, a leader in global life sciences solutions, introduces Trinity EvidenceFirst™, a high-value subscription service that allows biopharmaceutical companies to take advantage of real-world insights like never before.

OnKure, Inc. , a leader in discovery and development of next generation histone deacetylase (HDAC) inhibitors, entered into a clinical trial collaboration and supply agreement with Pfizer Inc. (NYSE: PFE) to support the clinical proof of concept study for MEKTOVI® (binimetinib) in combination with OKI-179, a highly potent and tolerable Class I HDAC inhibitor currently in Phase I for the treatment of NRAS melanoma.

According to the recent FDA SARS-CoV-2 Reference Panel Comparative Data released on September 15, among all the FDA EUA tests with returned results, DiaCarta’s QuantiVirus TM SARS-CoV-2 Test and QuantiVirus TM SARS-CoV-2 Multiplex Test both rank within the top 3 for product sensitivity. With limit of detection (LoD) at 600 NDU/ml, these tests are 300 to 900-folds better than the least sensitive tests listed (180,00

The sleep tech company’s CoolDrift™ Versa™ device is clinically-validated to calm racing mind, enabling relaxation and better-quality sleep [21-September-2020] PITTSBURGH , Sept. 21, 2020 /PRNewswire/ -- Ebb Therapeutics ® (Ebb) today announced the launch of the CoolDrift™ Versa™ (Versa™), the company’s second clinically-validated sleep wearable that leverages excl

Prostate Conditions Education Council works to stop the delayed diagnosis of prostate cancer due to COVID-19 by offering free screenings

In lieu of an in-person update to the media, Dr. Theresa Tam, Canada’s Chief Public Health Officer, issued the following statement

American Laboratory Products Company, Ltd. (ALPCO), a specialty in vitro diagnostics company, today announced the majority recapitalization of the company by Ampersand Capital Partners.